Drug Shortage Report for METHOTREXATE INJECTION USP
Report ID | 188454 |
Drug Identification Number | 02182955 |
Brand name | METHOTREXATE INJECTION USP |
Common or Proper name | METHOTREXATE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL INTRACEREBROVENTRICULAR INTRACEREBROVENTRICULAR INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL |
Packaging size | 1 x 2mL vial |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2023-07-11 | English | Compare |
v16 | 2023-07-10 | French | Compare |
v15 | 2023-07-10 | English | Compare |
v14 | 2023-06-20 | English | Compare |
v13 | 2023-06-19 | French | Compare |
v12 | 2023-06-19 | English | Compare |
v11 | 2023-06-10 | English | Compare |
v10 | 2023-05-29 | French | Compare |
v9 | 2023-05-29 | English | Compare |
v8 | 2023-05-27 | English | Compare |
v7 | 2023-05-08 | French | Compare |
v6 | 2023-05-08 | English | Compare |
v5 | 2023-05-06 | English | Compare |
v4 | 2023-03-31 | French | Compare |
v3 | 2023-03-31 | English | Compare |
v2 | 2023-03-31 | French | Compare |
v1 | 2023-03-31 | English | Compare |
Showing 1 to 17 of 17